Running To “Escape” Stress? It Could Lead to Dependence
A new study by researchers at the Norwegian University of Science and Technology (NTNU) explored whether “escapism” can help us to understand running motivation and exercise dependence.
PDL Grants Patent Licenses to Merck for Humanized Antibodies
The licensing of humanized antibody technology will build a commercial operation focused on the acute care hospital setting.
Nutra Pharma Reports Discovery of Gene Involved in Multiple Sclerosis
The research provides evidence that RPI-78M modulates the expression of this gene in laboratory assays.
Morphotek Expands Oncology Pipeline with Product Candidate from NCI
Morphotek is applying its antibody technologies to develop and optimize antibodies to cancer-associated proteins.
Genmab Appoints Annarie Lyles as Head of Business Development
Dr. Lyles replaces Dr. Ernst Schweizer, remains a member of the Genmab Board of Directors.
Fogarty Announces Awards for Biodiversity-Based Drug Discovery Research
Compounds from natural products continue to be the important sources of completely new chemistry.
ACD/Labs Opens new Office in the UK
The new office in the UK will serve local pharmaceutical, chemical, environmental, and academic markets.
Pfizer and Perlegen Form Genetics Research Collaboration
Researchers from both companies will conduct whole genome studies involving DNA samples from clinical trials.
Dharmacon and MIT Settle RNAi License Dispute
MIT has dismissed all of its legal claims against Dharmacon and its parent company Fisher Scientific International Inc.
Affymetrix and Vita Collaborate to Develop Microarray-based IVD Products
Vita Genomics is able to incorporate Affymetrix' patented arrays into its molecular diagnostic assays.
Gene Therapy for Muscular Dystrophy Fixes Frail Muscle Cells in Animal Model
Researchers used gene therapy to introduce a healthy copy of the gene dystrophin into mice with a condition that mimics muscular dystrophy.